Delivery Order SPE2DR25D3306-SPE2DR26F5F5Y
Award Date 1/7/26
Potential Completion Date 1/8/26
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,529.19 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of 36,000 units of Creon DR 100s capsules, with completion targeted for September 16, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, indicating this delivery...
- The Defense Logistics Agency (DLA) awarded a $1,963.44 delivery order to AmerisourceBergen Drug Corp for 36,000 unit capsules of Creon DR 100s, with a completion date of December 31, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is well-positioned to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for 36,000 units of Creon DR 100s capsules, valued at $2,704.53. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of December 12, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,301.44 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of 36,000 units of Creon DR 100S capsules. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 21, 2025, and performance will occur at the contractor's location in Conshohocken, Pennsylvania. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, and this order represents a...
- The Defense Logistics Agency awarded a $31,088.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of 36,000 units of Creon DR 100s capsules. The contract, which is not set-aside, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. Performance will be completed by August 20, 2025, with fulfillment...
- The Defense Logistics Agency awarded a delivery order valued at $14,549.41 to AmerisourceBergen Drug Corp for the supply of 36,000 units of Creon DR 100 milligram capsules. The contract is a firm fixed price delivery order with an ultimate completion date of December 15, 2025, and was competitively awarded without set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $3,088.91 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 mg capsules. This non-competitive, firm fixed price delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child contract under a larger vehicle, this delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $34,912.05 to AmerisourceBergen Drug Corp for the supply of 24,000 unit capsules of Creon DR 100s. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, representing a critical pharmaceutical supply for...
- The Defense Logistics Agency awarded a delivery order valued at $8.58K to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, with performance at the contractor's Conshohocken, Pennsylvania facility. The award, made on January 6, 2026, carries a firm fixed-price structure with an ultimate completion date of January 7, 2026, and was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,004.53 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 capsules, with an ultimate completion date of July 30, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, awarded competitively on July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Creon DR is an enzyme replacement therapy used to treat...